Insider Selling: HCA Holdings SVP Sells 15,000 Shares of Stock (HCA)
HCA Holdings (NYSE:HCA) SVP Juan Vallarino sold 15,000 shares of the stock in a transaction dated Friday, June 20th. The shares were sold at an average price of $57.50, for a total value of $862,500.00. Following the completion of the sale, the senior vice president now directly owns 72,419 shares of the company’s stock, valued at approximately $4,164,093. The sale was disclosed in a filing with the SEC, which is available at this link.
HCA Holdings (NYSE:HCA) traded down 2.53% during mid-day trading on Tuesday, hitting $56.54. The stock had a trading volume of 2,199,296 shares. HCA Holdings has a one year low of $35.20 and a one year high of $58.55. The stock has a 50-day moving average of $53.8 and a 200-day moving average of $50.59. The company has a market cap of $25.138 billion and a price-to-earnings ratio of 17.11.
HCA Holdings (NYSE:HCA) last issued its quarterly earnings data on Tuesday, April 29th. The company reported $0.84 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.85 by $0.01. The company had revenue of $9.68 billion for the quarter, compared to the consensus estimate of $8.90 billion. During the same quarter in the prior year, the company posted $0.79 earnings per share. The company’s quarterly revenue was up 5.3% on a year-over-year basis. On average, analysts predict that HCA Holdings will post $3.71 earnings per share for the current fiscal year.
A number of research firms have recently commented on HCA. Analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of HCA Holdings in a research note on Tuesday, June 3rd. They now have a $60.00 price target on the stock, up previously from $58.00. Separately, analysts at Mizuho raised their price target on shares of HCA Holdings from $57.00 to $60.00 in a research note on Tuesday, June 3rd. They now have a “buy” rating on the stock. Finally, analysts at Oppenheimer raised their price target on shares of HCA Holdings from $55.00 to $62.00 in a research note on Wednesday, April 30th. They now have an “outperform” rating on the stock. Three equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the stock. HCA Holdings has a consensus rating of “Buy” and an average price target of $55.50.
HCA Holdings, Inc (NYSE:HCA) is a holding company whose affiliates owns and operates hospitals and related health care entities.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.